- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01418911
Attachment Style of Type 2 Diabetics, and Cognitive, Social and Emotional Variables as Explanatory Factors of Adherence to Self-care Behavior and Diabetes Control
April 30, 2012 updated by: Assuta Hospital Systems
This study will expand the understanding of factors associated with adherence to self care and the diabetes control among diabetes type 2 patients.
The theoretical framework of the study incorporates central variables from two theoretical models: a cognitive model of health behavior - "Health Belief Model", and the Stress and Coping model.
The study is innovative in its focus on the association between the patient's attachment style and adherence to self care and diabetes control, a topic less studied among diabetes patients, in addition to cognitive, social and emotional variables.
Further emphasis is upon a comparison of the study model between males and females.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Liza Cnaani, MA
- Email: abarbnel_l@mac.org.il
Study Locations
-
-
-
Tel Aviv, Israel
- Maccabi Healthcare Services
-
Contact:
- Liza Cnaani, MA
- Email: abarbnel_l@mac.org.il
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
type 2 diabetes 40-70 years of age Hebrew speaking members of maccabi healthcare services
Description
Inclusion Criteria:
- type 2 diabetes
- 40-70 years of age
- Hebrew speaking
- members of maccabi healthcare services
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
diabetes type 2
type 2 diabetes patients 40-70 years of age hebrew speaking members of maccabi healthcare services
|
questionnaire only
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Anticipated)
December 1, 2012
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
August 16, 2011
First Submitted That Met QC Criteria
August 16, 2011
First Posted (Estimate)
August 17, 2011
Study Record Updates
Last Update Posted (Estimate)
May 1, 2012
Last Update Submitted That Met QC Criteria
April 30, 2012
Last Verified
July 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23/2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Patients
-
PfizerCompletedType 2 Diabetes PatientsUnited States
-
Shanghai HEP Pharmaceutical Co., Ltd.WithdrawnType 2 Diabetes Patients
-
Solvay PharmaceuticalsCompleted
-
Centre Hospitalier Universitaire DijonTerminatedPatients With Type 1 or Type 2 Diabetes | Patients With a Type A or B Behaviour ProfileFrance
-
Seoul National University HospitalCompletedPatients With Type 2 DiabetesKorea, Republic of
-
AstraZenecaCompletedAdult Patients With Type 2 Diabetes MellitusKorea, Republic of
-
Pharmalyte Solutions LLCNot yet recruitingHypomagnesemia in Type 2 Diabetic Patients
-
The First Affiliated Hospital of Xiamen UniversityUnknownOverweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes PatientsChina
-
Jordan University of Science and TechnologyCompletedPatients With Type 2 Diabetes (FSG: More Than 7.1 and Not Higher Than 15.8 mmol/L)Jordan
-
Vanderbilt UniversityCompletedType 2 Diabetes Mellitus | Obese PatientsUnited States
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Minneapolis Veterans Affairs Medical CenterUnited States Department of DefenseCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury)United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Rabin Medical CenterCompleted
-
University of PalermoRecruitingFamilial Mediterranean Fever | Non-celiac Gluten SensitivityItaly